07/26/2010 // US // Get Cancer Answers // News Desk
Washington – A device used for the treatment of lower back pain has sparked concern from U.S. reviewers due to a number of cancer cases linked to patients who have used the device. As reported by Reuters, an evaluation of the experimental Medtronic Inc spinal fusion device, Amplify, is set to be carried out by a Food and Drug Administration advisory panel Tuesday due to safety concerns.
FDA reviewers are quoted in the report as stating in a summary for the advisory panel, “The primary safety concern is the increased numbers of cancer events in patients treated with Amplify compared to the control group.”
Medtronic has reportedly stated that a “plausible biological mechanism” has not been found to show the device contributes to the development of cancer.
The latest in Cancer News